Terry-Ann Burrell
Director of Finance/CFO chez BEAM THERAPEUTICS INC.
Fortune : 3 M $ au 31/03/2024
Profil
Actuellement, Terry-Ann Burrell occupe le poste de directrice financière et trésorière de Beam Therapeutics, Inc. Mme Burrell est également membre du conseil d'administration de Recursion Pharmaceuticals, Inc. Dans sa carrière antérieure, elle a occupé le poste de directrice générale chez JPMorgan Securities LLC. Mme Burrell a obtenu un diplôme de premier cycle à l'université de Harvard et un MBA à la Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC.
0,10% | 26/04/2024 | 82 637 ( 0,10% ) | 3 M $ | 31/03/2024 |
| 01/04/2024 | 56 314 ( 0,03% ) | 561 451 $ | 31/03/2024 |
Postes actifs de Terry-Ann Burrell
| Sociétés | Poste | Début |
|---|---|---|
| BEAM THERAPEUTICS INC. | Director of Finance/CFO | 01/08/2019 |
| RECURSION PHARMACEUTICALS, INC. | Director/Board Member | 01/04/2020 |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Director/Board Member | 16/01/2024 |
Anciens postes connus de Terry-Ann Burrell
| Sociétés | Poste | Fin |
|---|---|---|
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01/08/2019 |
Formation de Terry-Ann Burrell
| Harvard University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RECURSION PHARMACEUTICALS, INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
